Cargando…
Peripheral arterial disease in polymyalgia rheumatica
Patients with polymyalgia rheumatica have been shown to have an increased risk of peripheral arterial disease on longitudinal follow-up. Possible explanations for this include premature atherosclerosis related to chronic inflammation, as with other inflammatory rheumatological conditions. Alternativ...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714105/ https://www.ncbi.nlm.nih.gov/pubmed/19519936 http://dx.doi.org/10.1186/ar2685 |
_version_ | 1782169636904632320 |
---|---|
author | Borg, Frances A Dasgupta, Bhaskar |
author_facet | Borg, Frances A Dasgupta, Bhaskar |
author_sort | Borg, Frances A |
collection | PubMed |
description | Patients with polymyalgia rheumatica have been shown to have an increased risk of peripheral arterial disease on longitudinal follow-up. Possible explanations for this include premature atherosclerosis related to chronic inflammation, as with other inflammatory rheumatological conditions. Alternatively, polymyalgia rheumatica can be associated with vasculitis, even in the absence of clinical giant cell arteritis, and peripheral vascular disease may represent subclinical vasculitis. Further work is required to elucidate the reasons for this increased risk. Currently, it would remain reasonable to aggressively control modifiable atherosclerotic risk factors. |
format | Text |
id | pubmed-2714105 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-27141052009-07-22 Peripheral arterial disease in polymyalgia rheumatica Borg, Frances A Dasgupta, Bhaskar Arthritis Res Ther Editorial Patients with polymyalgia rheumatica have been shown to have an increased risk of peripheral arterial disease on longitudinal follow-up. Possible explanations for this include premature atherosclerosis related to chronic inflammation, as with other inflammatory rheumatological conditions. Alternatively, polymyalgia rheumatica can be associated with vasculitis, even in the absence of clinical giant cell arteritis, and peripheral vascular disease may represent subclinical vasculitis. Further work is required to elucidate the reasons for this increased risk. Currently, it would remain reasonable to aggressively control modifiable atherosclerotic risk factors. BioMed Central 2009 2009-05-20 /pmc/articles/PMC2714105/ /pubmed/19519936 http://dx.doi.org/10.1186/ar2685 Text en Copyright © 2009 BioMed Central Ltd |
spellingShingle | Editorial Borg, Frances A Dasgupta, Bhaskar Peripheral arterial disease in polymyalgia rheumatica |
title | Peripheral arterial disease in polymyalgia rheumatica |
title_full | Peripheral arterial disease in polymyalgia rheumatica |
title_fullStr | Peripheral arterial disease in polymyalgia rheumatica |
title_full_unstemmed | Peripheral arterial disease in polymyalgia rheumatica |
title_short | Peripheral arterial disease in polymyalgia rheumatica |
title_sort | peripheral arterial disease in polymyalgia rheumatica |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714105/ https://www.ncbi.nlm.nih.gov/pubmed/19519936 http://dx.doi.org/10.1186/ar2685 |
work_keys_str_mv | AT borgfrancesa peripheralarterialdiseaseinpolymyalgiarheumatica AT dasguptabhaskar peripheralarterialdiseaseinpolymyalgiarheumatica |